vs

Side-by-side financial comparison of CAMDEN NATIONAL CORP (CAC) and GERON CORP (GERN). Click either name above to swap in a different company.

CAMDEN NATIONAL CORP is the larger business by last-quarter revenue ($64.3M vs $47.2M, roughly 1.4× GERON CORP). CAMDEN NATIONAL CORP runs the higher net margin — 34.0% vs -39.0%, a 73.0% gap on every dollar of revenue. Over the past eight quarters, GERON CORP's revenue compounded faster (1597.0% CAGR vs 22.6%).

Camden National Bank is a commercial bank headquartered in Camden, Maine, operating as the principal subsidiary of Camden National Corporation, a publicly traded bank holding company. Founded in 1875, the bank became a direct, wholly owned subsidiary of the holding company following a corporate reorganization in 1984. Following the 2025 merger with Northway Financial, the combined institution has approximately $7.0 billion in assets.

Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.

CAC vs GERN — Head-to-Head

Bigger by revenue
CAC
CAC
1.4× larger
CAC
$64.3M
$47.2M
GERN
Higher net margin
CAC
CAC
73.0% more per $
CAC
34.0%
-39.0%
GERN
Faster 2-yr revenue CAGR
GERN
GERN
Annualised
GERN
1597.0%
22.6%
CAC

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
CAC
CAC
GERN
GERN
Revenue
$64.3M
$47.2M
Net Profit
$21.9M
$-18.4M
Gross Margin
Operating Margin
-29.4%
Net Margin
34.0%
-39.0%
Revenue YoY
67.1%
Net Profit YoY
30.3%
EPS (diluted)
$1.29
$-0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CAC
CAC
GERN
GERN
Q1 26
$64.3M
Q4 25
$68.1M
Q3 25
$65.4M
$47.2M
Q2 25
$62.3M
$49.0M
Q1 25
$60.1M
$39.6M
Q4 24
$47.6M
Q3 24
$45.0M
$28.3M
Q2 24
$42.8M
$882.0K
Net Profit
CAC
CAC
GERN
GERN
Q1 26
$21.9M
Q4 25
$22.6M
Q3 25
$21.2M
$-18.4M
Q2 25
$14.1M
$-16.4M
Q1 25
$7.3M
$-19.8M
Q4 24
$14.7M
Q3 24
$13.1M
$-26.4M
Q2 24
$12.0M
$-67.4M
Operating Margin
CAC
CAC
GERN
GERN
Q1 26
Q4 25
41.5%
Q3 25
40.5%
-29.4%
Q2 25
28.5%
-25.4%
Q1 25
10.3%
-42.2%
Q4 24
38.7%
Q3 24
35.2%
-99.8%
Q2 24
34.7%
-7860.9%
Net Margin
CAC
CAC
GERN
GERN
Q1 26
34.0%
Q4 25
33.1%
Q3 25
32.4%
-39.0%
Q2 25
22.6%
-33.4%
Q1 25
12.2%
-50.1%
Q4 24
30.8%
Q3 24
29.1%
-93.5%
Q2 24
28.0%
-7639.8%
EPS (diluted)
CAC
CAC
GERN
GERN
Q1 26
$1.29
Q4 25
$1.33
Q3 25
$1.25
$-0.03
Q2 25
$0.83
$-0.02
Q1 25
$0.43
$-0.03
Q4 24
$1.00
Q3 24
$0.90
$-0.04
Q2 24
$0.81
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CAC
CAC
GERN
GERN
Cash + ST InvestmentsLiquidity on hand
$78.1M
Total DebtLower is stronger
$514.4M
Stockholders' EquityBook value
$710.0M
$248.7M
Total Assets
$7.0B
$567.4M
Debt / EquityLower = less leverage
0.72×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CAC
CAC
GERN
GERN
Q1 26
Q4 25
Q3 25
$78.1M
Q2 25
$77.7M
Q1 25
$83.7M
Q4 24
Q3 24
$60.3M
Q2 24
$116.9M
Total Debt
CAC
CAC
GERN
GERN
Q1 26
$514.4M
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
CAC
CAC
GERN
GERN
Q1 26
$710.0M
Q4 25
$696.6M
Q3 25
$676.4M
$248.7M
Q2 25
$652.1M
$259.5M
Q1 25
$640.1M
$268.2M
Q4 24
$531.2M
Q3 24
$529.9M
$292.3M
Q2 24
$508.3M
$306.7M
Total Assets
CAC
CAC
GERN
GERN
Q1 26
$7.0B
Q4 25
$7.0B
Q3 25
$7.0B
$567.4M
Q2 25
$6.9B
$555.2M
Q1 25
$7.0B
$562.5M
Q4 24
$5.8B
Q3 24
$5.7B
$444.9M
Q2 24
$5.7B
$449.4M
Debt / Equity
CAC
CAC
GERN
GERN
Q1 26
0.72×
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CAC
CAC
GERN
GERN
Operating Cash FlowLast quarter
$-13.6M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CAC
CAC
GERN
GERN
Q1 26
Q4 25
$63.9M
Q3 25
$36.1M
$-13.6M
Q2 25
$6.0M
$-27.4M
Q1 25
$1.0M
$-48.0M
Q4 24
$60.9M
Q3 24
$-14.5M
$-58.9M
Q2 24
$14.5M
$-53.5M
Free Cash Flow
CAC
CAC
GERN
GERN
Q1 26
Q4 25
$58.2M
Q3 25
$35.4M
Q2 25
$4.5M
Q1 25
$-727.0K
Q4 24
$55.4M
Q3 24
$-16.2M
Q2 24
$13.2M
$-53.7M
FCF Margin
CAC
CAC
GERN
GERN
Q1 26
Q4 25
85.5%
Q3 25
54.1%
Q2 25
7.3%
Q1 25
-1.2%
Q4 24
116.4%
Q3 24
-36.0%
Q2 24
30.8%
-6086.6%
Capex Intensity
CAC
CAC
GERN
GERN
Q1 26
Q4 25
8.4%
Q3 25
1.1%
Q2 25
2.4%
Q1 25
2.9%
Q4 24
11.7%
Q3 24
3.8%
0.0%
Q2 24
3.0%
23.4%
Cash Conversion
CAC
CAC
GERN
GERN
Q1 26
Q4 25
2.83×
Q3 25
1.70×
Q2 25
0.43×
Q1 25
0.14×
Q4 24
4.15×
Q3 24
-1.11×
Q2 24
1.21×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CAC
CAC

Net Interest Income$52.4M81%
Noninterest Income$12.0M19%

GERN
GERN

Segment breakdown not available.

Related Comparisons